adr_usa_0504|MITO|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
adr_usa_0504|MITO|Long Name|1|1|Stealth BioTherapeutics Corp Total Current Assets (Quarterly) (USD)|Stealth BioTherapeutics Corp Cash and Short Term Investments (Quarterly) (USD)|Stealth BioTherapeutics Corp Inventories (Quarterly) (USD)|Stealth BioTherapeutics Corp Net PP&E (Quarterly) (USD)|Stealth BioTherapeutics Corp Goodwill and Intangibles (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Current Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Long Term Liabilities (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Deposits (Quarterly) (USD)|Stealth BioTherapeutics Corp Book Value (Quarterly) (USD)|Stealth BioTherapeutics Corp Retained Earnings (Quarterly) (USD)|Stealth BioTherapeutics Corp Treasury Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp EV to Revenues|Stealth BioTherapeutics Corp EV to Earnings|Stealth BioTherapeutics Corp EV to Free Cash Flow|Stealth BioTherapeutics Corp EV to Assets (Quarterly)|Stealth BioTherapeutics Corp PS Ratio|Stealth BioTherapeutics Corp PE Ratio|Stealth BioTherapeutics Corp Price to Book Value|Stealth BioTherapeutics Corp PEG Ratio|Stealth BioTherapeutics Corp Debt to Equity Ratio|Stealth BioTherapeutics Corp Dividend Yield|Stealth BioTherapeutics Corp Shareholder Yield (TTM)|Stealth BioTherapeutics Corp Percent of Shares Outstanding Short|Stealth BioTherapeutics Corp Total Receivables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Payables (Quarterly) (USD)|Stealth BioTherapeutics Corp Total Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Return on Invested Capital|Stealth BioTherapeutics Corp Quality Ratio Score|Stealth BioTherapeutics Corp Momentum Score|Stealth BioTherapeutics Corp Beta (1Y)|Stealth BioTherapeutics Corp Sustainable Growth Rate (TTM)|Stealth BioTherapeutics Corp Institutional Investor Ownership Percentage|Stealth BioTherapeutics Corp Average Diluted Shares Outstanding (Quarterly)|Stealth BioTherapeutics Corp Total Employees (Annual)|Stealth BioTherapeutics Corp EPS Diluted (Quarterly) (USD)|Stealth BioTherapeutics Corp Shares Outstanding|Stealth BioTherapeutics Corp Repurchase of Capital Stock (Quarterly) (USD)|Stealth BioTherapeutics Corp Ordinary Shares Number (Quarterly)|Stealth BioTherapeutics Corp Payout Ratio|Stealth BioTherapeutics Corp Quick Ratio (Quarterly)|Stealth BioTherapeutics Corp Normalized Diluted EPS (Quarterly) (USD)|Stealth BioTherapeutics Corp Stock Buybacks (Quarterly) (USD)|Stealth BioTherapeutics Corp Effective Tax Rate (TTM)|Stealth BioTherapeutics Corp Return on Equity|Stealth BioTherapeutics Corp Net Income (TTM) (USD)|Stealth BioTherapeutics Corp Revenue (TTM) (USD)|Stealth BioTherapeutics Corp Dividend Per Share (Quarterly) (USD)|Stealth BioTherapeutics Corp Revenue (Quarterly) (USD)|Stealth BioTherapeutics Corp Gross Profit (Quarterly) (USD)|Stealth BioTherapeutics Corp SG&A Expense (Quarterly) (USD)|Stealth BioTherapeutics Corp Pre-Tax Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Net Interest Income (Quarterly) (USD)|Stealth BioTherapeutics Corp Price (USD)|Stealth BioTherapeutics Corp Total Return Price (USD)|Stealth BioTherapeutics Corp Enterprise Value (USD)|Stealth BioTherapeutics Corp 30-Day Average Daily Volume|Stealth BioTherapeutics Corp 1 Year Price Returns (Daily)
adr_usa_0504|MITO|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
adr_usa_0504|MITO||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
adr_usa_0504|MITO||5|5|114|114|0|114|0|114|114|114|0|114|121.666666667|0|0|0|0|91|0|0|1.44191919192|0|0|1.44600938967|0|15.2051282051|0|114|121.666666667|0|0|30.5|30.5714285714|0|39.2142857143|91.2|365|91.2|30.3333333333|0|114|0|0|91.2|0|0|0|91.2857142857|0|0|0|0|91.2|91.2|91.2|91.2|1.44600938967|1.44600938967|1.44600938967|1.44584382872|1.42528735632
adr_usa_0504|MITO||6|6|8|8|0|8|0|8|8|8|0|8|6|0|0|0|0|2|0|0|396|0|0|426|0|39|0|8|6|0|0|6|7|0|14|10|1|10|18|0|8|0|0|10|0|0|0|7|0|0|0|0|10|10|10|10|426|426|426|397|174
adr_usa_0504|MITO||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
adr_usa_0504|MITO|201712|201712|201712|5.92|4.1188||0.7959||298.441|24.5946|273.8464||-291.2861|-329.5568|||||||||||||||7.4546|0.0205|||||||20.384||-1.0827|||396.221|||-1.0847|||||||||3.5627|-22.07|-22.07|-1.5405|||||
adr_usa_0504|MITO|201803|201803|201803||||||||||||||||||||||||||||||||||20.384||-0.9979||||||-0.9953|||||||||3.496|-20.341|-20.341|-3.356|||||
adr_usa_0504|MITO|201806|201806|201806||||||||||||||||||||||||||||||||||20.384||-1.3274||||||-1.0418|||||||||4.29|-27.057|-27.057|-4.846|||||
adr_usa_0504|MITO|201809|201809|201809|5.0301|4.0783||0.5725||44.5209|31.6672|12.8538||-32.8912|-399.6797|||||||||||||||8.8263|0.0881|||||||20.384||-1.1148|||396.221|||-1.3273||||-92.193|||||4.755|-22.725|-22.725|-6.079|||||
adr_usa_0504|MITO|201812|201812|201812|13.293|10.855||0.499||402.229|40.611|361.618||-386.706|-426.269|||||||||||||||11.023|0.021|||||||33.0184|57|-0.8053|||396.221|||-0.8438||||-96.712|||||9.676|-26.589|-26.589|-6.881|||||
adr_usa_0504|MITO|201902|201812|201812||||||||||||||||||||||0||0.149|||||||||||||34.4416||||||||||||||||||12|12|524.4832||
adr_usa_0504|MITO|201903|201903|201903|72.094|70.497||0.433||38.935|26.48|12.455||33.923||||||||||||0||0.1313||9.605|||||||87.2162|18.3363||-2.4|35.0298||420.3575|||-1.2974||||-119.549|||||4.157|-43.178|-43.178|-4.475|12.8|12.8|559.5654|64641.9667|
adr_usa_0504|MITO|201904|201903|201903|||||||||||||||||||15.1073|||0||0.1122|||||||||87.2162||||||||||||||||||||||14.63|14.63|458.679|9555.7333|
adr_usa_0504|MITO|201905|201903|201903|||||||||||||||||||12.3915|||0||0.1061|||||||||87.2162||||||||||||||||||||||12|12|366.5506|4121.8333|
adr_usa_0504|MITO|201906|201906|201906|54.608|53.2||0.437||36.01|25.684|10.326||19.285|||||||||12.9078|||0||0.011||8.97|||||||87.0545|35.0333||-0.48||||||-0.48||||-108.242|||||6.064|-15.75|-15.75|-0.32|12.5|12.5|384.0655|6170.3667|
adr_usa_0504|MITO|201907|201906|201906|||||||||||||||||||22.7053|||0||0.0206|||||||||87.0545||||||||||||||||||||||12.5|12.5|401.4355|4319.8|
adr_usa_0504|MITO|201908|201906|201906|||||||||||||||||||16.1662|||0||0.0242|||||||||||||||||||||||||||||||8.9|8.9|275.3282|7121.9|
adr_usa_0504|MITO|201909|201909|201909|38.918|37.23||0.421||35.894|27.795|8.099||3.695|||||||||56.6923|||0||0.0268||7.284|||||||87.6329|35.0333||-0.48|||420.3998|||-0.48||||-102.047|||||6.269|-16.53|-16.53|-0.441|5.98|5.98|189.0922|17214.9667|
adr_usa_0504|MITO|201910|201909|201909|||||||||||||||||||63.0335|||0||0.045|||||||||84.4015||||36.392||||||||||||||||||6.4|6.4|212.5228|73846.1333|
adr_usa_0504|MITO|201911|201909|201909|||||||||||||||||||114.3182|||0||0.0653|||||||||||||||||||||||||||||||11.6071|11.6071|402.0196|29232.5667|
adr_usa_0504|MITO|201912|201912|201912|52.398|50.768||0.345||35.476|33.95|1.526||17.267|-497.997|||||1.5948|||6.8711||0.9406|0||0.1385||9.52|0.131||||||83.7638|36.3146|31|0.24|36.3934||436.7208||1.4954|0.24||||-71.728|||21.087||5.825|3.73|3.73|-0.442|3.26|3.26|84.1165|214999.1333|
adr_usa_0504|MITO|202001|201912|201912|||||||||||||||||||5.3114|||0||0.0994|||||||||||||||||||||||||||||||2.52|2.52|57.1854|308174.6|
adr_usa_0504|MITO|202002|201912|201912|||||||||||||||||||3.8992|||0||0.1801|||||||2.7962||||||36.3934||||||||||||||||||1.85|1.85|32.8018|154972.7|-84.5833
adr_usa_0504|MITO|202003|202003|202003|31.862|31.242||0.285||29.72|29.72|0||2.427||||||0.5407|||18.5941|||0||0.0777||6.513||||1|2.364||87.4364|36.3934||-0.48|36.3934||436.7208|||-0.48||||-44.09|||||5.18|-15.54|-15.54|-0.513|1.24|1.24|28.5198|1192063.2|-90.3125
adr_usa_0504|MITO|202004|202003|202003|||||||||||||||||||33.6046|||0||0.0777||||||1|2.5811||65.8928||||49.1316||||||||||||||||||1.66|1.66|64.9505|91763.0667|-88.6535
adr_usa_0504|MITO|202005|202003|202003|||||||||||||||||||39.6778|||0||0.0231||||||1|2.8261||4.3422||||49.1316||||||||||||||||||1.96|1.96|79.6899|124949.6667|-84.32
adr_usa_0504|MITO|202006|202006|202006|32.916|31.834||0.224||22.09|22.09|0||11.585||||||1.3115|||7.8201|||0||0.0094||5.003||||1|2.9092||1.6666|47.9492||-0.24|49.5061||594.0735|||-0.24||||-40.709|||||4.523|-12.369|-12.369|-0.441|1.83|1.83|69.1722|136738.6333|-85.36
adr_usa_0504|MITO|202007|202006|202006|||||||||||||||||||9.5294|||0||0.2957||||||1|3.0486||1.6666||||||||||||||||||||||2.23|2.23|88.9746|197250.6333|-82.16
adr_usa_0504|MITO|202008|202006|202006|||||||||||||||||||6.6356|||0||0.108||||||1|2.4548||1.6636||||49.5961||||||||||||||||||1.55|1.55|55.45|241058.8|-82.5843
adr_usa_0504|MITO|202009|202009|202009|||||||||||||||||||5.7794|||0||0.1974||||||1|2.4176||1.6641||||||||||||||||||||||1.35|1.35|45.5307|80705.4|-77.4247
adr_usa_0504|MITO|202010|202009|202009|||||||||||||||||||6.1121|||0|||||||||||||||||||||||||||||||||1.4277|1.4277|49.3844|48826.6|-77.3215